Carboxyesterase polypeptides for amide coupling

US11015180B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-11015180-B2
Application numberUS-201816218003-A
CountryUS
Kind codeB2
Filing dateDec 12, 2018
Priority dateDec 13, 2017
Publication dateMay 25, 2021
Grant dateMay 25, 2021

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

The present invention provides engineered carboxyesterase enzymes having improved properties as compared to a naturally occurring wild-type carboxyesterase enzymes, as well as polynucleotides encoding the engineered carboxyesterase enzymes, host cells capable of expressing the engineered carboxyesterase enzymes, and methods of using the engineered carboxyesterase enzymes in amidation reactions.

First claim

Opening claim text (preview).

The invention claimed is: 1. An engineered carboxyesterase comprising a polypeptide sequence having at least 80% sequence identity to SEQ ID NO: 2, wherein said engineered carboxyesterase comprises a substitution in said polypeptide sequence at position 282, wherein the amino acid positions of said polypeptide sequence are numbered with reference to SEQ ID NO:2, and wherein said engineered carboxyesterase exhibits greater enzymatic activity than wild-type T. fusca carboxyesterase of SEQ ID NO:2. 2. The engineered carboxyesterase of claim 1 , wherein said polypeptide sequence further comprises substitutions at positions selected from: 39, 39/323, 62, 62/117, 63, 64, 65, 66, 68, 69, 70, 71, 71/263, 77, 77/184, 103, 103/147, 104, 104/429, 105, 107, 107/185, 108, 109, 109/117, 110, 111, 113, 114, 115, 117, 118, 118/269, 118/349, 119, 126, 147, 153, 153/215, 164, 164/271, 174, 183, 184, 184/249, 185, 186, 187, 188, 190, 209, 210, 211, 212, 213, 213/271, 213/345, 214, 215, 215/271, 216, 217, 217/231, 224, 224/268/372, 231, 249, 249/284, 263, 268, 269, 270, 270/470, 271, 271/416, 276, 277, 278, 279, 280, 281, 281/374, 283, 283/429, 284, 284/438, 285, 286, 311, 317, 320, 320/323, 320/323/372, 320/372/376, 320/376/377, 321, 323, 324, 345, 349, 372, 372/376, 373, 374, 376, 377, 405, 416, 420, 427, 428, 429, 438, and 470, wherein the amino acid positions of said polypeptide sequence are numbered with reference to SEQ ID NO: 2. 3. The engineered carboxyesterase of claim 1 , wherein said amino acid at position 282 is a polar amino acid. 4. The engineered carboxyesterase of claim 1 , wherein said engineered carboxyesterase comprises an amino acid substitution selected from: X282Q, X282S, and X282T, and wherein the amino acid positions of said polypeptide sequence are numbered with reference to SEQ ID NO: 2. 5. The engineered carboxyesterase of claim 1 , wherein said polypeptide sequence is selected from: SEQ ID NOs: 4, 6, 8, 68, 70, 72, 74, 76, 78, 80, 82, 84, 86, 88, 90, 92, 94, 96, 98, 100, 102, 104, 106, 108, 110, 112, 114, 116, 118, 120, 122, 124, 126, 128, 130, 132 and 134. 6. The engineered carboxyesterase of claim 1 , wherein said engineered carboxyesterase comprises improved amidation activity as compared to the wild-type T. fusca carboxyesterase of SEQ ID NO:2. 7. The engineered carboxyesterase of claim 1 , wherein said engineered carboxyesterase exhibits greater enzymatic activity than wild-type T. fusca carboxyesterase on a substrate comprising isobutylamine. 8. The engineered carboxyesterase of claim 1 , wherein said engineered carboxyesterase exhibits greater enzymatic activity than wild-type T. fusca carboxyesterase on the substrate set comprising isobutylamine and ethyl benzoate. 9. The engineered carboxyesterase of claim 1 , wherein said engineered carboxyesterase exhibits greater enzymatic activity than wild-type T. fusca carboxyesterase in producing a product comprising N-isobutyl-benzamide. 10. The engineered carboxyesterase of claim 1 , further comprising at least one substitution selected from: L343V, L372L, L320W/G, L214R, L271Y and L65G, wherein said engineered carboxyesterase exhibits greater enzymatic activity than wild-type T. fusca carboxyesterase, and wherein the amino acid positions of said polypeptide sequence are numbered with reference to SEQ ID NO:2. 11. The engineered carboxyesterase of claim 1 , further comprising at least one substitution selected from: L268A, L63A/R, L189Q/I/E, L214R, L381L, and L69W, wherein said engineered carboxyesterase exhibits greater enzymatic activity than wild-type T. fusca carboxyesterase, and wherein the amino acid positions of said polypeptide sequence are numbered with reference to SEQ ID NO:2. 12. The engineered carboxyesterase of claim 1 , wherein said engineered carboxyesterase is purified. 13. The engineered carboxyesterase of claim 1 , wherein said engineered carboxyesterase is immobilized on a solid support. 14. A composition comprising at least one engineered carboxyesterase of claim 1 .

Assignees

Inventors

Classifications

  • C12N9/18Primary

    Carboxylic ester hydrolases {(3.1.1)} · CPC title

  • Carboxylesterase (3.1.1.1) · CPC title

  • Genes encoding for enzymes or proenzymes · CPC title

  • Biofuels, e.g. bio-diesel · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US11015180B2 cover?
The present invention provides engineered carboxyesterase enzymes having improved properties as compared to a naturally occurring wild-type carboxyesterase enzymes, as well as polynucleotides encoding the engineered carboxyesterase enzymes, host cells capable of expressing the engineered carboxyesterase enzymes, and methods of using the engineered carboxyesterase enzymes in amidation reactions.
Who is the assignee on this patent?
Codexis Inc
What technology area does this patent fall under?
Primary CPC classification C12N9/18. Mapped technology areas include Chemistry & Metallurgy.
When was this patent published?
Publication date Tue May 25 2021 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 4 related publications on this page (citations in our corpus or others sharing the same primary CPC).